Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Conference News THT 2025

Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT

Todd Neale

February 11, 2025

News Conference News AHA 2024

Nasal Bumetanide Safe, Effective in Healthy Adults

Yael L. Maxwell

November 18, 2024

News Daily News

Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home

Caitlin E. Cox

September 16, 2024

News Conference News ESC Heart Failure 2024

Better Natriuresis With IV Furosemide and Metolazone in Chronic HF Patients

Michael O'Riordan

May 13, 2024

News Daily News

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

L.A. McKeown

December 08, 2023

News ESC 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Michael O'Riordan

August 27, 2023

News Conference News ESC Heart Failure 2023

ENACT-HF: Natriuresis-Guided Diuretic Protocol Beats Usual Care

Shelley Wood

May 25, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2022

Caitlin E. Cox

December 01, 2022

News Conference News AHA 2022

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

Todd Neale

November 05, 2022

News Conference News ESC 2022

Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR

L.A. McKeown

August 27, 2022

News Conference News ESC Heart Failure 2022

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

Shelley Wood

May 26, 2022

News Conference News ESC Heart Failure 2019

Weaning Off Diuretics in Stable Heart Failure? ReBIC-1 Hints at Possibilities

Shelley Wood

May 28, 2019

News Conference News ESC Heart Failure 2019

Device-Based Therapy Offers REPRIEVE From Decongestion in Acute HF: TARGET 1 and 2

Shelley Wood

May 25, 2019

News Daily News

Quicker Diuretics Not Associated With Better Outcomes in Acute Heart Failure

Todd Neale

March 25, 2018

News Industry News

scPharmaceuticals Announces Positive Results from Pivotal Trial of its Novel Subcutaneous Furosemide Formulation in Patients with Heart Failure

November 03, 2015

News Daily News

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

September 22, 2015

News Opinion Fellow Talk

‘Absence of Evidence Is Not the Evidence of Absence’ - How Do We Translate Clinical Research Into Clinical Practice?

Gagan Singh, MD

January 26, 2015

News Daily News

Induced Diuresis with Matched Hydration Reduces Contrast Nephropathy

January 17, 2012

News Daily News

REMEDIAL II Published: New Therapy Prevents Contrast-Induced Kidney Damage

Caitlin E. Cox

August 19, 2011

News Daily News

Women More Likely Than Men to Develop CIN after Angiography

L.A. McKeown

April 29, 2011

Advertisement

Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT

Nasal Bumetanide Safe, Effective in Healthy Adults

Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home

Better Natriuresis With IV Furosemide and Metolazone in Chronic HF Patients

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

ENACT-HF: Natriuresis-Guided Diuretic Protocol Beats Usual Care

TCTMD’s Top 10 Most Popular Stories for November 2022

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

Weaning Off Diuretics in Stable Heart Failure? ReBIC-1 Hints at Possibilities

Device-Based Therapy Offers REPRIEVE From Decongestion in Acute HF: TARGET 1 and 2

Quicker Diuretics Not Associated With Better Outcomes in Acute Heart Failure

scPharmaceuticals Announces Positive Results from Pivotal Trial of its Novel Subcutaneous Furosemide Formulation in Patients with Heart Failure

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

‘Absence of Evidence Is Not the Evidence of Absence’ - How Do We Translate Clinical Research Into Clinical Practice?

Induced Diuresis with Matched Hydration Reduces Contrast Nephropathy

REMEDIAL II Published: New Therapy Prevents Contrast-Induced Kidney Damage

Women More Likely Than Men to Develop CIN after Angiography

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content